Sylvester Comprehensive Cancer Center
Every day men and women from fire departments across the country put their lives on the line, and at risk, in more ways than you can imagine.
The Miami Dolphins biggest fundraiser of the year now has some big name entertainment. Grammy-Award winners Sheryl Crow and Melissa Etheridge will headline the Dolphins Cancer Challenge VI Finish Line Celebration on February 20th at Sun Life Stadium.
A college student who is fighting cancer is also fighting his insurance company.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine will be one of the sites offering the landmark precision medicine trial, NCI-MATCH (Molecular Analysis for Therapy Choice) – a trial that will open to patient enrollment in July.
Peter Tarjan, Ph.D., is more than Professor Emeritus in Biomedical Engineering at the University of Miami and a docent at the University’s Lowe Art Museum. He is also a survivor of the Holocaust.
The Pap Corps Champions for Cancer Research, a South Florida-based grassroots organization, has awarded Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine a $3.6 million gift to advance research in precision cancer medicine at Sylvester, South Florida’s only Cancer Center of Excellence.
In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer.
Florida Surgeon General and Secretary of Health John Armstrong, M.D., presented the state’s Cancer Center of Excellence Award to Sylvester Comprehensive Cancer Center on April 17, making it the only South Florida cancer center to […]
New research, at a local cancer center, has found that a drug used for erectile dysfunction shows promise for patients with malignant throat tumors.
There is a simple new test designed to avoid unnecessary prostate biopsies.